(Q68264367)

English

The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin

scientific article published on 01 November 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

author name string

M. Treskes

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659819

23 October 2022

U. Holwerda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659819

23 October 2022

I. Klein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659819

23 October 2022

H. M. Pinedo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659819

23 October 2022

W. J. van der Vijgh

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659819

23 October 2022

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

6 November 1991

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1659819

23 October 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0006295291903478?httpAccept=text/xml

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

https://api.elsevier.com/content/article/PII:0006295291903478?httpAccept=text/plain

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

2125-2130

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer

3

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Biochemical modulation of cisplatin toxicity

4

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDP.

6

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin

7

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy

8

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Inactivation of cis-diamminedichloroplatinum (II) in blood by sodium thiosulfate

9

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate

12

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Phase I Clinical and Pharmacokinetic Study of Diethyldithiocarbamate as a Chemoprotector From Toxic Effects of Cisplatin

15

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer

16

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Can WR-2721 be improved upon?

17

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Pharmacokinetics of WR-2721.

19

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide

20

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721

21

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy

22

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

HPLC determination of cis-diamminedichloroplatinum(II) in plasma and urine with UV detection and column-switching

23

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.

24

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721

26

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Measurement of S-2-(3-Aminopropylamino)ethanethiol (WR1065) in Blood and Tissues

28

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Disposition of unchanged cisplatin in patients with ovarian cancer

29

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Pharmacokinetics of carboplatin after i.v. administration

30

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations

31

1 reference

10.1016/0006-2952(91)90347-8

https://api.crossref.org/works/10.1016/0006-2952(91)90347-8

23 October 2022

Identifiers

10.1016/0006-2952(91)90347-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1659819%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68264367&oldid=2188495815"